Obesity is recognized as an epidemic health problem worldwide. In humans, the accumulation of omental rather than subcutaneous fat appears to be tightly linked to insulin resistance, type 2 diabetes and cardiovascular disease. Differences in gene expression profiles in the adipose tissue comparing non-obese and obese subjects have been well documented. However, to date, no comparative proteomic studies based on omental fat have investigated the influence of obesity in protein expression. In this work, we searched for proteins differentially expressed in the omental fat of non-obese and obese subjects using 2D-DIGE and MS. Forty-four proteins, several of which were further studied by immunoblotting and immunostaining analyses, showed significant differences in the expression levels in the two groups of subjects. Our findings reveal a clearly distinctive proteomic profile between obese and non-obese subjects which emphasizes: i) reduced metabolic activity in the obese fat, since most down-regulated proteins were engaged in metabolic pathways; and ii) morphological and structural cell changes in the obese fat, as revealed by the functions exerted by most up-regulated proteins. Interestingly, transketolase and aminoacylase-1 represent newly described molecules involved in the pathophysiology of obesity, thus opening up new possibilities in the study of obesity.
Introduction
Obesity is one of the most important public health problems facing the world today and has increased dramatically over the last decades in children and adolescents [1] . Obese subjects suffer from decreased life quality and expectancy as well as increased risk of suffering insulin resistance, type 2 diabetes, cardiovascular disease (CVD), hepatic steatosis, pulmonary and muscular pathologies, psychological disorders and cancer, among others [2] . A person's weight and body composition are likely determined by interaction between his/her genetic makeup and social, cultural, behavioral, and environmental factors.
The intake of energy-dense foods, especially when combined with reduced physical activity, is very likely to contribute to the high prevalence of obesity; however, the existence of complex systems that regulate energy balance calls for a broader view of this paradigm [3] . In humans, the adipose tissue is dispersed throughout the body with major intra-abdominal depots around the omentum, intestines, and perirenal areas, as well as in subcutaneous depots in the buttocks, thighs, and abdomen. These two fat depots, the subcutaneous and the omental fat, exhibit unique biochemical and cellular properties, such as response to sex hormones, and different secretion profiles [4] , including a different lipolytic program [5] . Moreover, the omental, but not the subcutaneous, fat drains directly into the portal circulation, and some data point out to excessive free fatty acid release from the omental adipose tissue in central obesity [6] . In fact, it is well established that the size of the omental, more than the subcutaneous, fat is strongly related to a higher risk of obesity-related co-morbidities, including insulin resistance, type 2 diabetes, dyslipidemia and CVD. As a consequence of extensive recent investigation, the adipose tissue is no longer regarded a mere fat reservoir, but an endocrine organ which cross-talks with other essential organs like the liver, the muscle, the pancreas, and the brain, being a crucial regulator of wholebody homeostasis.
Gene expression studies (i.e. microarrays and RT-PCR) using adipose tissue from obese and non-obese subjects have yielded important insights into the pathogenesis of obesity and related diseases, (reviewed in [7] ). Results pointed out that: i) obesity represents a chronic inflammatory condition, since genes related with inflammation are up-regulated in response to obesity; ii) the differentiation state of obese adipocytes is altered; and iii) the expression of adipogenic genes is decreased in obesity [8] [9] [10] [11] . As far as the latter is concerned, it has been suggested that the limited lipogenic and/or adipogenic capacity of obese adipocytes might lead to spillover of excess lipids to other tissues, and lipotoxicity could contribute to the pathogenesis of type 2 diabetes [12] .
At the protein level the knowledge about human adipose tissue is limited. A very few proteomic studies have been published using either whole adipose tissue or isolated cells from both fat depots (reviewed in [13] ). The majority of these works have studied human adipogenesis or adipose tissue secretome. Recently, however, our group and others have resorted to 2D-DIGE and MS to explore the differences between omental and subcutaneous fat [14] [15] [16] . Despite of some drawbacks inherent to 2-DE analysis (mainly the poor representation of lowabundant or very hydrophobic proteins as well as those with extreme pI and molecular weight), the quantitative comparison of proteins in two or more conditions based on 2D-DIGE/MS is a widespread, robust methodology to assess differential protein expression. This approach provides great analytical precision, dynamic range and sensitivity, therefore allowing a reproducible and reliable differential analysis [17] . Nevertheless, to date, no proteomic studies based on omental fat have investigated the influence of obesity in protein expression, given that the omental adipose tissue has been tightly linked to obesityassociated co-morbidities. In this work, we have compared for the first time the omental fat from non-obese and morbidly obese subjects by 2D-DIGE and MS, revealing 44 modulated proteins in response to obesity. Our findings emphasize a noticeably decreased expression of proteins related to metabolic processes in response to obesity together with a downregulation of mitochondrial enzymes, which is consistent with a reduced metabolic activity in the obese adipose tissue. In addition, most of the proteins found up-regulated in obesity develop structural functions in the cell, which account for the morphological changes undergone by obese adipocytes. Therefore, our results support a neatly distinctive biological profile in the omental fat of obese and non-obese subjects regarding protein expression.
2.
Materials and methods
Study design
Omental fat from morbidly obese (n = 6) and non-obese (n = 6) subjects obtained during surgery were analyzed by a proteomic approach using 2D-DIGE. Samples were labelled using fluorophore dye-swapping to avoid labelling bias, combined in pairs and separated by electrophoresis. Image analysis revealed modulated proteins which were identified by MS.
Results validation was performed by Western Blot with an additional set of subjects. Immunostaining assays were performed to study selected proteins not only in adipose tissue samples, but also in human omental adipocyte cultures. The 3T3-L1 cell line was used to study whether these proteins were modulated in the adipocyte differentiation process. ), and age ranged from 39 to 58 years. All these subjects had been submitted for elective surgical procedures (cholecystectomy, surgery of abdominal hernia and gastric by-pass surgery). During surgery, biopsies of adipose tissues were obtained after an overnight fast, washed in chilled 9 g/L NaCl solution, partitioned into pieces, and immediately frozen in liquid nitrogen and stored at −80°C until protein extraction. The surgeon aimed to obtain the samples from similar anatomical locations in all the subjects. All women were of Caucasian origin and reported that their body weight had been stable for at least three months before the study. None of the subjects had type 2 diabetes or any other systemic disease apart from obesity and all were free of any infections within the previous month before the study. Liver disease and thyroid dysfunction were specifically excluded by biochemical work-up. Other exclusion criteria for those patients included the following: 1) clinically significant hepatic, neurological, or other major systemic disease, including malignancy; 2) history of drug or alcohol abuse, defined as >80 g/day, or serum transaminase activity more than twice the upper normal range limit; 3) elevated serum creatinine concentrations; 4) acute major cardiovascular event in the previous 6 months; 5) acute illnesses and current evidence of chronic inflammatory or infectious diseases; and 6) mental illness rendering the subjects unable to understand the nature, scope, and possible consequences of the analysis. The study was conducted according to the recommendations of the Declaration of Helsinki and was approved by the ethics committees of Hospital Dr. Josep Trueta (Girona, Spain). Signed informed consent was obtained from all subjects.
Biological samples

2D-DIGE analysis
Proteins were extracted from omental adipose tissue biopsies (100 mg) by using the 2D Grinding Kit (GE Healthcare, Uppsala, Sweden) in Lysis Buffer (7 M urea, 2 M thiourea, 4% CHAPS, and 30 mM Tris-HCl pH 8.5) containing 50 mM DTT. The extract was shaken for 30 min at room temperature and centrifuged at 15,000 ×g for 30 min. Proteins were precipitated with the 2D-CleanUp Kit (GE Healthcare) and redissolved in Lysis Buffer. The protein concentration was determined using RC/DC Protein Assay (Bio-Rad Laboratories, Hercules, CA, USA). Proteins were labelled according to the manufacturer's instruction (GE Healthcare). Briefly, 50 μg of adipose tissue protein extracts was minimally labelled with 400 pmol of the N-hydroxysuccinimide esters of Cy3 or Cy5 fluorescent cyanine dyes on ice in the dark for 30 min. All experiments comprised an internal standard containing equal amounts of each cell lysate, which was labelled with Cy2 dye. The labelling reaction was quenched with 1 μl of 10 mM lysine on ice in the dark for 10 min. The internal standard and the individual omental fat extracts from nonobese and obese subjects were combined and run in a single gel (150 μg total proteins). Proteins extracts were diluted in Rehydration Buffer (7 M urea, 2 M thiourea, 2% CHAPS, 0.8% (v/v) IPG buffer 3-11NL), reduced with 50 mM DTT, and applied by cup-loading to 24 cm IPG strips pH 3-11NL, which were previously rehydrated with Rehydration Buffer containing 100 mM hydroxyethyl disulfide (DeStreak, GE Healthcare). The first and second dimensions together with the equilibration step were performed following the procedure previously described [14] .
Image acquisition and analysis
After SDS-PAGE, gels were scanned with a Typhoon 4100 scanner (GE Healthcare) at 100 μm resolution using appropriate individual excitation and emission wavelengths, filters and photomultiplier (PMT) sensitivity for each Cy2, Cy3 and Cy5 dyes (PMT values: 510, 510 and 475 respectively). Gel images were analyzed with the DIA (Differential in-gel Analysis) module of the DeCyder v7 software (GE Healthcare) for automatic spot detection, background subtraction, quantification and normalization with low experimental variation (DeCyder Differential Analysis Software User Manual, version 7; GE Healthcare, 2009). The Biological Variation Analysis (BVA) module utilized those images individually processed with the DIA module to Fig. 1 -Representative silver stained 2D gel of omental adipose tissue proteins using 24 cm pH3-11NL (left to right) strips in the first dimension and 12% PAGE-SDS gels in the second dimension. Numbers correspond to differentially expressed protein spots as indicated in Table 1 . Supplemental Fig. 1 provides a more convenient visualization of the differential protein spots on the silver stained 2D gel.Representative silver stained 2D gel of omental adipose tissue proteins using 24 cm pH3-11NL (left to right) strips in the first dimension and 12% PAGE-SDS gels in the second dimension. Numbers correspond to differentially expressed protein spots as indicated in Table 1 . Supplemental Fig. 1 provides a more convenient visualization of the differential protein spots on the silver stained 2D gel. 
2.5.
In-gel trypsin digestion and mass spectrometry
Protein spots showing significantly altered expression levels in the 2 groups of samples by DeCyder Software were selected for gel excision from silver-stained gels, digested automatically on a Proteineer DP robot (Bruker Daltonik, Bremen, Germany) using the protocol of [18] and analyzed in an Ultraflex MALDI TOF/TOF mass spectrometer (Bruker Daltonik) [19] to obtain the corresponding MALDI-MS and MALDI-MS/MS spectra. In a first step, MALDI-MS spectra were acquired by averaging 300 individual spectra in the positive ion reflector mode at 50 Hz laser frequency in a mass range from 800 to 4000 Da. In a second step, precursor ions showing in the MALDI-MS mass spectrum were subjected to fragment ion analysis in the tandem (MS/MS) mode to average 1000 spectra. Peak labelling, internal calibration based on two trypsin autolysis ions with m/z = 842.510 and m/z = 2211.105, as well as removal of known trypsin and keratin peptide masses were performed automatically using the flexAnalysis 2.2 software (Bruker Daltonik). No smoothing or any further spectral processing was applied. MALDI-MS and MS/MS spectra were manually inspected in detail and reacquired, recalibrated and/or relabelled using the aforementioned programs and homemade software when necessary.
Database searching
MALDI-MS and MS/MS data were combined through the BioTools 3.0 program (Bruker Daltonik) to search a nonredundant protein database (NCBInr 20091022;~7.0 × 10 6 entries; National
Centre for Biotechnology Information, Bethesda, USA), using the Mascot 2.2 software (Matrix Science, London, UK; http:// www.matrixscience.com) [20] . Other relevant search parameters were set as follows: enzyme, trypsin; fixed modifications, carbamidomethyl (C); allow up to 1 missed cleavage; peptide tolerance ±20 ppm; MS/MS tolerance ±0.5 Da. Protein scores greater than 81 were considered significant (p < 0.05).
Cell culture and adipocyte differentiation
Isolated human omental pre-adipocytes (Zen-Bio, Inc. Raleigh, NC, USA) were cultured with omental pre-adipocytes medium (Zen-Bio, Inc.) at 37°C and 5% CO 2 and differentiated using omental differentiation medium (Zen-Bio, Inc.) according to the method outlined by Ortega et al. [21] . Two weeks after the initiation of differentiation, cells appeared rounded with large lipid droplets in the cytoplasm and were considered mature adipocytes. Murine 3T3-L1 fibroblasts (CCL 92.1, American Type Culture Collection) were grown to confluence in DMEM containing 10% calf serum. The differentiation to adipocytes was induced according to the procedure described by Ortega et al. [21] . On days 0, 3, 5 and 9, three replicated cell samples were separately collected for later immunoassays.
Immunoblotting analysis
Fat tissue or cultured cells were homogenized in radioimmnuno precipitation assay (RIPA) buffer as described in [14] . Protein extracts (ca. 10 μg) were loaded, resolved on SDS-PAGE and transferred to Hybond ECL nitrocellulose membranes by conventional procedures. Membranes were stained with 0. . Blots were incubated with the appropriate IgG-HRP-conjugated secondary antibody. Immunoreactive bands were visualized with ECL-plus reagent kit (GE Healthcare). Blots were exposed for different times; exposures in the linear range of signal were selected for densitometric evaluation. Optical densities of the immunoreactive bands were measured using Image J analysis software. Statistical comparisons of the densitometry data were carried out using the Student's t test for samples, and results were expressed as means± standard deviation (SD) using SPSS 16.0 (SPSS Inc., Illinois, USA). Statistical significance was set at p< 0.05.
Immunohistochemistry
Five-micron sections of formalin-fixed paraffin-embedded adipose tissue were deparaffinised and rehydrated prior to antigen unmasking by boiling in 1 mM EDTA, pH 8. Sections were blocked in normal serum and incubated overnight with rabbit anti-TKT (1:500 dilution) or rabbit anti-ACY-1 (1:200 dilution) antibodies. Secondary antibody staining was performed using the VECTASTAIN ABC kit (Vector Laboratories, Inc. Burlingame, CA) and detected with diaminobenzidine (DAB, Vector Laboratories, Inc.). Sections were counterstained with hematoxylin prior to dehydration and coverslip placement, and examined under a Nikon Eclipse 90i microscope. As a negative control, the procedure was performed in the absence of primary antibody.
Immunofluorescence
Frozen adipose tissue sections or cultured cells were fixed with 4% paraformaldehyde and permeabilized for 30 min with 0.1% Triton X-100 in PBS. Staining was performed overnight at 4°C with rabbit anti-TKT (1:500 dilution) or with rabbit anti-ACY-1 (1:400 dilution) antibodies, washed, and visualized using Alexa Fluor 546 goat anti-rabbit antibody (1:500; Molecular Probes Inc., OR, USA). The slides were counterstained with DAPI (4,6-diamidino-2-phenylindole) to reveal nuclei. The lipophilic fluorescence dye BODIPY 493/503 was used for lipid droplet labelling according to the manufacturer's instruction (Molecular Probes Inc.). The slides were examined under a Leica TCS SP5 fluorescent microscope (Heidelberg, Germany). As a negative control, the assay was performed in the absence of primary antibody.
Results
Proteomic analysis of obese and non-obese adipose tissue samples
To detect proteins differentially expressed in obesity, omental fat samples from morbidly obese (n = 6) and nonobese (n = 6) females were analyzed by 2D-DIGE. Protein extracts were labelled using dye-swapping with either Cy3 or Cy5 fluorescent dye to avoid labelling bias arising from the fluorescence properties of gels at different wavelengths. Then each Cy3/Cy5-labelled sample pair was mixed with a Cy2-labelled internal standard and loaded onto each gel. After 2-DE, the Cy2, Cy3 and Cy5 channels were individually imaged from each gel (Supplemental Fig. 1 ). Automated image analysis performed with DeCyder software detected approximately 2700 spots per gel in the 3-11 NL pH range with a molecular mass of 10-150 kDa, of which 1200 spots were matched throughout all gels. Multivariate PCA showed that the "non-obese group" was efficiently discriminated from the "obese group" (data not shown). DeCyder statistical analyses showed that 70 protein spots were differentially expressed at p < 0.05 considering only those spots present in all gels. These spots were excised from silver-stained gels, digested with trypsin, and analyzed by MALDI-MS followed by database search. Fifty-six spots, which corresponded to 44 unique proteins could be identified ( Fig. 1 and Table 1 ). Twenty proteins were increased and 24 decreased in response to obesity.
Functional classification of the proteins differentially expressed
To understand the biological relevance of protein expression changes in response to obesity, the Protein Analysis Through Evolutionary Relationship (PANTHER) application (http:// www.pantherdb.org/) was used. This classification system uses information on protein sequence to assign a gene to an ontology group on the basis of the Gene Ontology (GO) terms http://www.geneontology.org/. Thus, the two sets of up-and down-regulated proteins were searched for significantly over-represented (p < 0.05) GO terms. Two key Biological Process classes were found significantly enriched in the group of down-regulated proteins: Metabolic Process and Generation of Precursor Metabolites and Energy, while three key Biological Process classes (Cellular Process, Developmental Process and Cellular Component Organization) were significantly enriched in the set of up-regulated proteins. Likewise, the categorization based on the Molecular Function GO category showed that most down-regulated proteins accounted for one key significant class, Catalytic Activity, while Structural Molecule Activity revealed as the unique key GO term with significant enrichment in the up-regulated proteins from obese adipose tissue (Fig. 2) .
In addition, PANTHER application mapped the 44 differentially expressed proteins into parent and child categories with regard to their Molecular Function and Biological Process GO Table 2 ), highlighting that most of the down-regulated proteins were engaged in metabolic pathways. Our results have also revealed that the set of downregulated proteins comprised numerous (14 out of 24, 58%) mitochondrial enzymes, overall supporting a reduced metabolic activity in the obese adipose tissue.
terms (Supplementary
Validation of differential protein expression
Western Blot analyses were performed in an additional set of non-obese and morbidly obese women for two proteins whose expression in human adipose tissue had not been previously documented, TKT and ACY-1, together with two molecules, HSP70 and FABP5 that had been earlier studied in fat and/or in obesity and related co-morbidities. One of these proteins was shown up-regulated (HSP70) and the other three were found down-regulated (TKT, ACY-1 and FABP5) in response to obesity. Immunoblotting analysis using an antibody against TKT confirmed that this protein was over-expressed (p < 0.05) in the non-obese group of subjects, confirming 2-DE findings (Fig. 3) . Likewise, ACY-1 levels were significantly more abundant (p < 0.05) in the non-obese subjects (Fig. 3 ), in agreement with 2D-DIGE results. Both TKT and ACY-1 were studied by immunostaining methods, as well as in the adipocyte differentiation process. Immunoblotting analysis revealed that HSP70 was significantly increased in obese vs. non-obese individuals (p < 0.05), thus confirming 2D-DIGE results (Fig. 3) . By using an antibody anti-FABP5, immunoblotting analysis revealed an over-expression of FABP5 protein in the omental adipose tissue from non-obese compared to obese subjects; however this result did not reach statistical significance (p = 0.06) mostly due to the high SD observed in non-obese samples (data not shown). It must be noted that Western Blot assay may fail to validate particular protein isoforms found differentially expressed by 2D-DIGE/MS as they rely on antibodies lacking the necessary specificity.
Immunostaining analyses
Immunohistochemical and immunofluorescence approaches were performed to determine the cellular distribution of TKT and ACY-1 proteins in biopsies of omental fat given that, as far as we know, these proteins have not been earlier analyzed in this tissue. TKT was assayed in sections of omental adipose tissue by both techniques revealing similar results. Immunofluorescence detection showed a bright staining pattern mainly in the cytoplasm of adipocytes and of stromalvascular fraction (SVF) cells, as well as in the nuclei of a few cells (Fig. 4A) . To determine whether the stained nuclei pertained to adipocytes, immunofluorescence analysis from a cellular culture of human pre-adipocytes and differentiated adipocytes was performed. This analysis showed that in preadipocytes TKT was localized in the cytoplasm as well as in the nucleus, while in adipocytes only the cytoplasm but not the nucleus was stained (Fig. 4B and C) . TKT expression was also confirmed in adipose tissue macrophages by co-staining assays using CD68 (not shown). ACY-1 was also assayed in sections of omental fat by immunostaining analyses, which showed that ACY-1 was expressed in the cytoplasm as well as in the nucleus of adipocytes and SVF cells, including omental mesothelial cells (Supplemental Fig. 2A and 2B ). Immunofluorescence analysis revealed the presence of ACY-1 in the nucleus of cultured human omental pre-adipocytes (Fig. 5A) , while in differentiated adipocytes ACY-1 localized around cytosolic lipid droplets and, to a lesser extent, in the nucleus (Fig. 5B and  5C ). In addition, we had also performed immunofluorescence analysis in 3T3-L1 cells during the adipogenic process. As illustrated in Supplemental Fig. 3A , ACY-1 was localized exclusively in 3T3-L1 fibroblast nuclei (day 0), as was the case for human pre-adipocytes; however, in 3T3-L1 differentiated adipocytes (day 9), ACY-1 was shown around lipid droplets in the cytoplasm, as well as in the majority of the nuclei (Supplemental Fig. 3B and 3C ). 
3.5.
3T3-L1 adipogenesis
To further study TKT and ACY-1 proteins, we performed immunoblotting analysis with proteins extracted during the adipogenic maturation of 3T3-L1 cells using the previously described specific antibodies. TKT and ACY-1 were significantly augmented with adipocyte differentiation in parallel to the expression of FABP4, which was used as an adipogenesis control (Fig. 6 ).
Discussion
Over the last years an increasing number of studies have focused in the analysis of gene expression to gain insight into obesity and related pathologies. However only a few number of studies have resorted to proteomic methods to identify human fat proteins associated to these disorders. In the present study we have employed a proteomic approach based on 2D-DIGE and MALDI-MS to uncover differences in protein expression using biopsies of omental fat from non-obese and morbidly obese individuals, reporting for the first time a set of 44 proteins that are significantly modulated in these two sets of subjects. Our study has focused on omental adipose tissue as this fat depot has been long associated with augmented risk of suffering pathologies related to obesity [22] . The down-regulation of proteins related to metabolic processes such as Amino Acid Metabolism, Carbohydrate Metabolism and Lipid Metabolism suggests a reduction of metabolic activity in the obese omental fat, and is consistent with previous mRNA studies [8] [9] [10] 23] ; thus, Ortega et al. [10] demonstrated the down-regulation of the main lipogenic enzymes in obese omental fat using a large cohort of individuals. In this scenario, these findings provide evidence for an impaired capacity of the adipose tissue to function as an energy reservoir. In addition, it is noteworthy the high number of mitochondrial enzymes included in the set of down-regulated proteins in the obese adipose tissue, 14 proteins out of 24, which is consistent with the reduction in the oxidative metabolism in obesity. Our findings are in agreement with previous microarray analysis revealing a coordinated down-regulation of catabolic pathways operating in the mitochondria such as: fatty acid B Fig. 4 -Immunofluorescence staining of TKT in human omental adipose tissue, human pre-adipocytes and human adipocytes differentiated in vitro. In fat biopsies TKT is mainly shown in the cytosol of adipocytes and other SVF cells, but is also observed in the nuclei of a few cells (four white circles) (A). In human pre-adipocytes TKT is shown both in the cytoplasm and the nucleus (B). In human differentiated adipocytes TKT is exclusively observed in the cytosol (C). Images are representative of adipose tissue sections collected from three subjects (A) and three replicates (B and C).
oxidation, tricarboxylic acid cycle and electron transport chain [24] . In addition, a strong correlation between impaired adipocyte mitochondrial activity and/or content and obesity has been well documented [25] [26] [27] . Decreased mitochondrial capacity in adipocytes may alter adipocyte insulin sensitivity and/or function due to the high energetic requirements for fatty acid storage, adipokine secretion [28] , insulin signalling [29] , and glucose uptake. Therefore, the relatively high number of mitochondrial proteins found down-regulated in our study is consistent with previous evidences.
The set of up-regulated proteins, which pertain to the following significantly enriched classes: Cellular Process, Developmental Process, Cellular Component Organization, and Structural Molecule Activity, suggests that the enlargement of the obese adipocytes, by increasing fat storage, is accompanied by: i) cytoskeleton changes, such as alteration of LMNA, LMNB1 and integrin alpha 7; ii) changes in the extracellular matrix (ECM), such as collagen (COL6A3) and lumican; and iii) tissue structure modifications, such as alteration in epithelial cytokeratins, CK-7, CK-8 and CK-19, compatible with omental mesothelium changes. Our findings showing the upregulation of proteins controlling cell architecture and tissue remodelling are in agreement with previous transcriptomic studies reporting that the expansion of adipose tissue is associated with a remodelling of ECM together with changes of fat cell cytoskeleton [23, 30] compatible with the need to adapt fat pads as adiposity increase.
Several relevant proteins highlighted by our study were more in-depth analyzed. Transketolase (TKT) expression levels were reduced in obese patients. To our knowledge this is the first time that a link between TKT and obesity is reported. This protein is a thiamine diphosphate (ThDP)-dependent enzyme that catalyzes several reactions in the nonoxidative branch of the Pentose Phosphate Pathway (PPP). In mammalian cells, the main function of PPP is to produce the reduced form of nicotinamide-adenine dinucleotide phosphate (NADPH), which functions in detoxification processes and lipid biosynthesis. Another function of PPP is to convert hexose into pentose, which is required for nucleic acid synthesis [31] . TKT haploinsufficient mice showed a markedly reduction in adipose tissue (77%) [32] which could be induced by NADPH deficiency, limiting the production of lipids in the fat. The reduced levels of TKT found in the group of obese vs. non-obese subjects could be explained by the occurrence of a compensatory mechanism through which the obese adipose tissue would prevent further enlargement. In this scenario, during the period of dynamic obesity large amounts of NADPH are required for fatty acid biosynthesis, and an increase in TKT function is expected. In contrast, it is well known that lipogenic pathways are reduced in established obesity [10] and TKT down-regulation could be a late and adaptive process, aimed at limiting a further development of fat mass. Immunostaining methods showed for the first time the expression of TKT in human omental adipose tissue. TKT, an ubiquitous enzyme engaged in multiple metabolic pathways, was widely distributed in adipocytes as well as other stromal cells. TKT was present mainly in the cytoplasm of adipose cells, but a few nuclei also expressed the protein. Interestingly, the nuclei of human pre-adipocytes expressed TKT in contrast to fully differentiated adipocytes, in which TKT was only observed in the cytoplasm. A nuclear localization of TKT had already been described [33] ; in this regard, it is interesting to mention that in a highly proliferative state increased cell division rate would require large amounts of phosphate pentose, which would account for the nuclear localization of TKT. On the other hand, mature adipocytes keep pentose phosphate consumption to a minimum while consuming many NADPH molecules for lipogenesis, which would explain TKT localization in the cytoplasm of mature adipocytes. Taken together, these findings highlight the potential role of this protein in adipose tissue and adipogenesis.
2D-DIGE and immunoblotting analyses have shown significant down-regulation of aminoacylase-1 (ACY-1) with obesity. ACY-1 is a cytosolic, homodimeric, zinc-binding enzyme that function in the catabolism and retrieval of acylated amino acids. ACY-1 expression has been found associated to renal carcinoma [34] and to an inborn metabolic disorder [35] . Nevertheless, this is the first report on ACY-1 expression in human fat. The nuclear localization of ACY-1 is striking. In agreement with our finding, this enzyme had been previously found in the nucleus of rat normal proximal tubular cells [34] . It is possible that several unidentified nuclear proteins are substrates for ACY-1. It is noteworthy that ACY-1 physically interacts and functionally modulates sphingosine kinase 1, SPHK1 [36] , a lipid kinase that converts sphingosine and ATP to sphingosine-1-phosphate (S1P). S1P is a potent signalling molecule involved in angiogenesis and cell growth among other cellular processes [37] . Of note, we have shown that both ACY-1 and SPHK1 are associated with adipogenesis in 3 T3-L1 cells (Fig. 6 and Supplemental Fig.  4 ) as already found with the latter [38] . These results collectively support the hypothesis that the SPHK1/ACY-1 system could play a role in obesity. Further studies are underway to explore ACY-1 functional role in adipose tissue.
Our results based on the 3T3-L1 adipocytes differentiation process have shown for the first time an increment of ACY-1 and TKT levels. Long-lasting fat excess has been evidenced to reduce adipogenesis in adipose tissue to limit further expansion of fat mass [8] [9] [10] [11] . We hypothesize that the diminished levels of ACY-1 and TKT proteins in obesity stem from the impaired adipogenic capacity of obese adipocytes.
The proteomic analysis has enabled the identification of other relevant proteins involved in obesity or whose expression in fat has been widely documented. Results revealed the overexpression in obese subjects of HSP70. HSPs not only serve as chaperones, mainly controlling protein folding of newly translated polypeptides but also protect cells against many chronically and acutely stressful conditions [39] . In spite of the numerous cellular processes in which HSP70 takes part, it can be hypothesized that the higher levels of HSP70 found in the omental fat from obese patients would serve to reduce the cellular stress associated to obesity. In skeletal muscle, evidences have shown that there is a decreased expression of HSP70 in type 2 diabetes patients [40, 41] and in mice models an elevation of HSP70 protected against obesity-induced hyperglycemia, hyperinsulinemia, glucose intolerance and insulin resistance [41] . Nevertheless, no similar studies have been conducted in adipose tissue to date. We performed Western Blot analyses to compare omental fat samples from obese patients with and without type 2 diabetes. Interestingly, in agreement with these evidences, our results revealed that the amount of HSP70 was significantly lower in type 2 diabetes obese subjects than in obese without type 2 diabetes (p= 0.007), as illustrated in Supplemental Fig. 5 . Therefore this result supports a protection role for HSP70.
It is well established that monoamine oxidase A (MAOA), a mitochondrial enzyme involved in the oxidative deamination catabolism of neurotransmitters and exogenous amines, is highly expressed in the adipocyte-enriched fraction of human adipose tissue [42] . Our results showed reduced levels of MAOA in obese subjects, which is in agreement with an earlier report revealing reduced MAOA activity in the adipose tissue from obese subjects [43] . Our study also showed reduced Values for relative intensity obtained after densitometry of the bands are means ± SD. * p < 0.005 and ** p < 0.05 for comparisons between TKT, and ACY-1 levels at day 9 vs. day 0, respectively (B). FABP4 was used as an adipogenesis control. The results were normalized for GAPDH density. Representative images of three independent analyses. expression levels of FABP5 in obese individuals, in consistence with previous studies in subcutaneous fat [44] . FABP5 is a relevant adipose tissue protein that facilitates lipid usage in metabolic pathways and plays a role in metabolic syndrome, insulin resistance, type 2 diabetes, and atherosclerosis, as elucidated in studies based on genetically modified mice [45] . Mice lacking FABP5 was protected against dietinduced obesity, insulin resistance and other related diseases [46] . Ongoing studies in our laboratory attempt to evaluate whether these results might be extrapolated to humans.
In summary, this work is, to our knowledge, the first proteomic study on omental fat comparing non-obese and obese people and represents one of the few proteomic analyses in human adipose tissue. Our findings evidence a clearly distinctive biological profile of obese and non-obese subjects highlighting a noticeably decreased expression of proteins related to metabolic processes and an increased expression of proteins that develop structural functions in the cell in response to obesity. Besides, our study has revealed that TKT and ACY-1 are promising new players involved in obesity. Our results will strengthen the understanding of molecular pathogenesis of obesity, whilst the identified proteins can be regarded as potential targets for future therapeutic strategies.
Supplementary materials related to this article can be found online at doi:10.1016/j.jprot.2011.09.016.
